← All articles

What Are the Leading Causes of Lung Cancer in Non-Smokers?

Lung cancer is strongly associated with smoking, but it can also develop in people who have never smoked.

What Are the Leading Causes of Lung Cancer in Non-Smokers?
Dr James Wilson Consultant Clinical Oncologist
Enquire today
Jump to:

For someone diagnosed without a history of smoking, one of the first questions is often straightforward: why did this happen?

There is not always a clear answer.

Lung cancer in people who have never smoked can be associated with radon, second-hand smoke, air pollution, occupational exposures and certain biological factors. In some people, no specific cause can be identified at all.

What caused the cancer is only one part of the picture. Once lung cancer has been diagnosed, the immediate priorities are establishing exactly what type it is, how far it has spread and whether molecular testing identifies changes that could influence treatment.

Lung Cancer Can Develop Without Smoking

Smoking remains the leading cause of lung cancer overall, but it is not a requirement for the disease to develop. People who have never smoked can still acquire changes within lung cells that eventually allow those cells to grow and divide abnormally.

While smoking is a well-established risk factor, questions are also increasingly raised about vaping and how its potential health effects compare with cigarette smoking. These discussions are important, but they also highlight that smoking history alone does not determine whether someone may develop lung cancer.

Lung cancers arising in never-smokers can also have different biological characteristics from cancers strongly associated with tobacco exposure.

For patients considering personalised lung cancer treatment, the characteristics of the tumour become particularly important. Molecular testing may identify changes that influence which treatments are most likely to be effective.

Radon Exposure

Radon is a naturally occurring radioactive gas produced by uranium present in rocks and soil. It cannot be seen, smelled or tasted and can enter buildings from the ground beneath them.

Long-term exposure to elevated radon levels can damage cells in the lungs and increase the risk of lung cancer. The risk is particularly high when radon exposure is combined with smoking, but radon is also a recognised cause of lung cancer in people who do not smoke.

Radon levels vary across the UK, so some homes and workplaces are more likely to have elevated levels than others. Testing is the only reliable way to determine how much radon is present in a particular building.

Second-Hand Tobacco Smoke

Never having smoked does not necessarily mean never having been exposed to tobacco smoke.

Second-hand smoke contains many of the same harmful substances inhaled by someone who actively smokes. Long-term exposure at home, at work or in other enclosed environments can therefore increase lung cancer risk in people who have never smoked themselves.

The risk is substantially lower than with active smoking, but evidence still shows a measurable increase in lung cancer risk among never-smokers exposed to second-hand tobacco smoke.

UK smoking restrictions have reduced exposure in workplaces and public indoor spaces, although historical exposure may remain relevant for people who spent many years living or working around smokers.

Air Pollution

Outdoor air pollution is another recognised lung cancer risk factor. Fine particulate matter, particularly PM2.5, can travel deep into the lungs, where long-term exposure can contribute to biological changes associated with cancer development.

For an individual, the risk from air pollution is considerably smaller than the risk from smoking. However, it remains important because large numbers of people may be exposed over long periods.

Traffic emissions, industrial pollution and other sources contribute to outdoor air pollution. Reducing exposure where practical can form part of wider lung cancer prevention, although individuals cannot always control the environment in which they live or work.

Workplace and Environmental Exposures

Some lung cancers are associated with carcinogenic substances encountered at work.

Asbestos is one of the best-known examples. Exposure increases the risk of lung cancer as well as mesothelioma, and disease may not become apparent until decades after the original exposure.

Other recognised occupational risks include silica, prolonged exposure to diesel exhaust and substances such as arsenic, beryllium, cadmium and nickel.

Because lung cancer can develop many years after exposure, occupational history can be important even when someone left a particular job decades earlier.

Have Questions About a Lung Cancer Diagnosis?

A lung cancer diagnosis can feel particularly confusing when you have never smoked. Knowing the cancer type, stage and molecular features can help provide a clearer picture of the treatment options available.

Dr James Wilson provides specialist oncology consultations for patients seeking personalised guidance about lung cancer diagnosis, treatment options and complex treatment decisions.

Discuss Your Diagnosis with Dr Wilson

Genetics and Family History

A diagnosis in someone who has never smoked can understandably raise questions about whether lung cancer runs in families.

Most lung cancers are not directly inherited. However, having a close relative with lung cancer can influence risk, potentially through a combination of inherited susceptibility and shared environmental factors.

It is also important to distinguish inherited genetics from genetic changes found within the tumour. When considering whether lung cancer is hereditary, many of the mutations identified during tumour testing are acquired during life rather than inherited from a parent.

A cancer can therefore be driven by genetic alterations without being a hereditary cancer.

Why Tumour Mutations Matter in Never-Smokers

Certain molecular alterations are found more frequently in lung cancers occurring in people who have never smoked, particularly lung adenocarcinoma. These may involve genes such as EGFR, ALK, ROS1 and others.

These alterations should not be described as causes in the same way as asbestos, radon or second-hand smoke. They are changes within cancer cells that help drive the cancer's growth.

Their clinical importance becomes particularly clear after diagnosis because some can be treated with targeted medicines. For example, EGFR-mutated lung cancer may respond to treatments designed to block abnormal EGFR signalling.

This is one reason molecular testing plays such an important role in modern non-small cell lung cancer care.

Previous Lung Disease and Medical Treatment

Certain long-term lung diseases have also been associated with an increased risk of lung cancer. Pulmonary fibrosis is one example.

Previous radiotherapy involving the chest can also increase lung cancer risk in some circumstances, although this is usually a long-term risk and needs to be considered in context.

Most people who have received radiotherapy do not go on to develop lung cancer. Modern radiotherapy techniques are also designed to limit unnecessary radiation exposure to healthy surrounding tissues wherever possible.

What If There Is No Clear Cause?

For some patients, no identifiable explanation emerges.

Someone may never have smoked, have no significant occupational or radon exposure, no strong family history and no medical history that clearly accounts for the diagnosis.

Cancer develops through changes accumulating within cells, and some of these can arise through normal biological processes and ageing without an identifiable external trigger.

The leading causes of lung cancer are therefore best understood as factors that influence risk rather than a checklist that can always explain why one individual developed the disease.

Once cancer has been diagnosed, its subtype, stage and molecular profile are generally more useful for deciding what happens next. At this stage, discussing these findings with an experienced consultant oncologist can help patients understand what the results mean and how they may influence the available treatment options.

Looking for Specialist Advice About Lung Cancer Treatment?

Whether or not you have ever smoked, treatment decisions after a lung cancer diagnosis depend on the cancer's stage, subtype, molecular characteristics and your individual circumstances.

Dr James Wilson offers specialist lung cancer consultations for patients seeking clear guidance about radiotherapy, chemotherapy, immunotherapy, targeted treatments and personalised treatment planning.

✓ Specialist expertise in lung cancer
✓ Personalised treatment discussions
✓ Review of molecular and treatment options
✓ Video and in-person appointments

Request a Consultation

Does Being a Non-Smoker Change Lung Cancer Treatment?

Treatment is based primarily on the characteristics of the cancer rather than smoking history alone.

Depending on the diagnosis, options may include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy or a combination of approaches. Molecular testing can be particularly valuable in non-small cell lung cancer because identifying a targetable alteration may significantly change the recommended treatment.

If several treatment approaches are being considered, or if you would like greater clarity around the recommended plan, seeking a second opinion can help you better understand the available options, the reasoning behind them, and the factors that may influence how successful lung cancer treatment is likely to be in your individual case.

Smoking history remains medically relevant, but never having smoked does not make a lung cancer diagnosis less serious or mean that symptoms should be investigated differently. The aim is to build an individualised treatment plan around the biology and extent of the cancer, alongside the patient’s health and priorities.

About Dr James Wilson

Lung cancer in non-smokers can arise through several pathways, and in some patients there is no single identifiable cause. Once a diagnosis is established, the biology and extent of the cancer become more important for treatment planning than identifying exactly why it developed.

Dr James Wilson is a consultant clinical oncologist in private practice in London, specialising in lung cancer and advanced radiotherapy. His work includes radiotherapy, chemotherapy, immunotherapy, targeted therapies and other systemic cancer treatments. He helps patients understand their diagnosis and make informed, individualised decisions about treatment.

Posted 19th August 2026
Enquire today